Inhibition of Caspase-2 Activity in Human Jurkat T-cell Lymphoma Cells by Splice Switching Oligonucleotide to its pre-mRNA | Zendy

Dmitry D. Zhdanov | Zendy; Anna A. Plyasova | Zendy; Yulia A. Gladilina | Zendy; M. V. Pokrovskaya | Zendy; S. Alexandrova | Zendy; Н. Н. Соколов | Zendy

Open Access

Inhibition of Caspase-2 Activity in Human Jurkat T-cell Lymphoma Cells by Splice Switching Oligonucleotide to its pre-mRNA

Author(s) -

Dmitry D. Zhdanov,

Anna A. Plyasova,

Yulia A. Gladilina,

M. V. Pokrovskaya,

S. Alexandrova,

Н. Н. Соколов

Publication year - 2019

Publication title -

biomedical chemistry research and methods

Language(s) - English

Resource type - Journals

ISSN - 2618-7531

DOI - 10.18097/bmcrm00108

Subject(s) - jurkat cells , casp , rna splicing , microbiology and biotechnology , oligonucleotide , messenger rna , splice , caspase 2 , exon , alternative splicing , biology , chemistry , apoptosis , caspase , rna , gene , programmed cell death , genetics , biochemistry , t cell , protein structure , immune system , protein structure prediction

Caspase-2 is a key enzyme thinvolved in induction of apoptosis. The caspase-2 level is regulated by alternative splicing (AS) of its mRNA. The aim of this work was to determine the ability of an oligonucleotide complementary to Casp-2 pre-mRNA to induce AS. This oligonucleotide blocked the binding of splicing-regulating proteins to their sites at the end of exon 9 of Casp-2 pre-mRNA, leading to induction of AS of Casp-2 mRNA. The decrease in expression of full-size active splice-variant (Casp-2L) and the increase the expression of a shortened variant (Casp-2S) was demonstrated in human T-cell lymphoma Jurkat cell line. The expression level of total Casp-2 remained unchanged. Disproportion of splice variants of Casp-2 led to inhibition of enzymatic activity of caspase-2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research